Quantitative Endoscopy of H&N

Phase 2

Completed

• Conditions: Head and Neck Cancer
• Interventions: Other: Spatially registered endoscopy

• Registration Number: NCT02704169
• Lead Sponsor: University Health Network, Toronto

Brief Summary

The last decade has seen progressive advances in RT delivery, such as intensity modulated radiation therapy (IMRT)and image-guided radiation therapy (IGRT), which now allow highly precise radiation dose delivery. Together, IMRT and IGRT offer the potential of more selective treatment of the primary tumour and surrounding neck nodes by reducing the dose inflicted on critical organs at risk without compromising tumour dose and. IMRT has been shown to significantly decrease radiation-induced toxicity, and is now considered standard treatment for H\&N tumors. With these advances in delivery technology, the accurate definition of the target is emerging as the weakest link in the radiotherapeutic treatment chain. Accurate target definition is the primary link on which all subsequent treatment planning and delivery depend and is therefore critical for successful RT. Incorrect target definition can result in poorer outcomes through either less tumour control, more normal tissue toxicity, or both. Computed x-ray tomography (CT) is the standard volumetric imaging modality for RT because of its high resolution, accurate definition of anatomy and its intrinsic measure of electron density necessary for accurate dose calculation. However, its ability to distinguish between tumour and normal tissue is limited due to a lack of contrast for structures of similar electron density and image artifacts for objects of high density. This additional noise can result in large inter-observation variability. Disease visible on endoscopy can be contoured and registered to the planning CT, allowing inclusion of superficial disease invisible on the volumetric CT image dataset into the treatment plan.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-06-27
• Study Start: 2013-07
• Study First Submitted QC: 2016-03-08
• Study First Posted: 2016-03-09
• Primary Completion: 2019-08-12
• Study Completion: 2019-08-12
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-18
• Last Update Posted: 2022-10-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Age ≥ 18 years
• Histologic diagnosis of squamous cell carcinoma
• Primary cancer of the H&N
• Intention to treat using external beam radiation therapy as part of standard radiotherapy.
• Ability to provide written informed consent to participate in the study

Exclusion Criteria

• Prior complete or partial radiation therapy to H&N
• Prior complete or partial surgery of the tumour
• Contraindications to full dose radiation therapy including pregnancy, lactation, connective tissue disorders, serious co-morbid illness
• Concurrent illness or condition that precludes subject from undergoing endoscopy or CT scanning
• Psychiatric or addictive disorders that preclude informed consent or adherence to protocol

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Spatially registered endoscopy for H&N cancer	Spatially registered endoscopy	-

Primary Outcome Measures

Name	Time	Method
Difference between inter-observer variation (V) of endoscopic gross tumor volume and of standard gross tumor volume	18 months	Determine if the inter-observer variation (V) of spatially registered endoscopic gross tumor volume contours is significantly less than standard gross tumor volume contours in primary H\&N tumors treated with radiation therapy
Difference between endoscopic gross tumor volume contours (GTV-endo) and standard gross tumor volume contours (GTV-std)	18 months	Determine if spatially registered endoscopic gross tumor volume contours (GTV-endo) and standard gross tumor volume contours (GTV-std) are significantly different in primary H\&N tumors treated with radiation therapy

Secondary Outcome Measures

Name	Time	Method
Difference between dose distribution using endoscopic gross tumor volume and using standard gross tumor volume	18 months	Determine if the dose distributions using spatially registered endoscopic GTV contours and standard GTV contours are significantly different in primary H\&N tumors treated with radiation therapy with regard to both normal tissue radiation exposure and tumor coverage

Trial Locations

Locations (1)

Princess Margaret Cancer Centre; 🇨🇦 Toronto, Ontario, Canada